Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Zengen, Inc. develops and commercializes peptide drugs. Its products help to prevent infection and inflammation through application of its patented peptide technologies. The company's technologies help to modulates inflammatory and immune responses. Zengen was founded in 1999 and is located in Woodland Hills, CA

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Miller Brewing Co. manufactures beer and fermented malt liquors. The company's principal beer brands are Miller Lite, Miller Genuine Draft and Miller High Life. It imports Pilsner, Urquell, Peroni Nastro Azzurro and Foster's and has craft brews Leinenkugel's and Henry Weinhard's. The company was founded by Frederick J. Miller in 1855 and is headquartered in Milwaukee, WI

John I. Haas, Inc. processes & trades hops and hop products. The company owns and operates hop farms, pellet plants, cold-storage warehouses, CO2 extraction facilities and other operations. John I. Haas was founded in 1914 and is headquartered in Washington, DC.

Pharmaceuticals

Shanghai Qianyin Technology Co., Ltd., established on 2015-10-27, The scope of business includes engaging in medical technology,food processing technology,Ecotechnology,Technology transfer in the field of information intelligence technology,technology development,Planning of cultural and artistic exchange activities,Special Design for Architectural Decoration Construction Engineering,Cleaning service,Real estate brokerage,Sales of building decoration materials,Investment Management Consulting. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND.

LanthioPep BV specializes in vivo stability of therapeutic and diagnostic imaging peptides. Its products include pancyte, lanthi apelin and galanin agonist. The company is headquartered in Groningen, the Netherlands.

Noevir Co., Ltd. is engaged in the manufacture and sale of cosmetics, pharmaceutical products and dietary supplement as well as sale of cosmetic accessories. It operates in Cosmetics, Pharmaceutical Products, Food and Others business division. The Cosmetics division is engaged in the manufacture and sale of cosmetics and toiletries, as well as sale of cosmetic accessories. The Pharmaceutical Products division is engaged in the manufacture and sale of pharmaceutical products. The Food division is engaged in the manufacture and sale of dietary supplement. The Others division is engaged in the purchase and sale of apparel, aircraft and ships, as well as the non regular air freight service. The company was founded in April 1964 and is headquartered in Kobe, Japan.

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Symrise GmbH & Co. KG develops and produces flavors, fragrances, cosmetic ingredients and aroma chemicals. It supplies cosmetic raw materials and active ingredients to the international fragrance, cosmetics and food industry. It's core competencies are extraction and distillation-separation techniques used to isolate natural flavor components. With its new ayurveda Extrapone product range, it offers components from traditional ayurvedic plants and herbs such as sandalwood, lotus flower, cinnamon, ginger and neem. Founded in 2003, the company is headquartered in Holzminden, Germany.

Antibenda (Ningxia) Biotechnology Co., Ltd., established on 2021-04-29, Business scope includes biotechnology extension services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Bio-organic fertilizer research and development;Bio-feed R&D;Research and development of compound microbial fertilizer;Fermentation process optimization technology research and development;Research and development of bio-based materials technology;Animal Husbandry Professional and Auxiliary Activities;Agricultural Science Research and Experimental Development;Intelligent Agricultural Management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

UMC Utrecht Holding BV engages in utilization and commercialization of academic researches. It offers research support and training services. The company was founded in 1996 and is headquartered in Utrecht, the Netherlands.

Lysando AG is a private company headquartered in Liechtenstein. The firm provides research and development services to the life science pharmaceuticals.\nThe company says this about itself: Lysando AG with subsidiaries in Regensburg and Bangkok was founded in Liechtenstein in 2009. Lysando AG is focused on the development of its proprietary Artilysin(R) platform to become the world's leading antimicrobial technology. Artilysin(R) technology has already been successfully established in the fields of medical devices and veterinary medicine. With licensing Artilysin(R) to AiCuris, the technology has now gained a foothold in the field of human pharmaceutics.The Artilysin(R) technology is effective against all germs classified as particularly dangerous by the WHO. Artilysin(R) is resistance breaking, environmentally friendly and gently to the microbiome. As of today, Lysando AG has granted over a dozen licenses to global companies.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.